Paediatric Sleep in Autism: Sensory and Routine Factors

Sleep difficulty affects an estimated 50 to 80 percent of autistic children, against general-population childhood rates of around 25 percent. The biological mechanisms (melatonin synthesis, sensory hyperarousal, cognitive carry-over) are reasonably well-characterised. The good news for parents: most autistic children improve with a combination of sensory-targeted environment, predictable routine and, where appropriate, melatonin. This piece covers what the picture looks like, what to try, when melatonin fits in, and when to ask for specialist support.

What it actually looks like

Common patterns in autistic children aged 6 to 17:

• Long sleep latency. Even when tired, it often takes much longer than 30 minutes to fall asleep. The mind continues processing the day; the sensory environment continues registering.
• Bedtime sensory friction. Specific textures, sounds, smells or light that have been fine for years suddenly become intolerable. Pyjamas with the wrong seam, the duvet that is now too heavy, the radiator clicking, the streetlight outside the window.
• Night waking with full alertness. Often around 3am or 4am, with the child fully awake and unable to settle back. Different in shape from the typical-development child's brief night waking.
• Early waking. Many autistic children wake at 5am or 5:30am and are immediately fully active; the morning rhythm starts earlier than the household is ready for.
• Restless or fragmented sleep visible to parents. Movement, talking, sometimes wandering. Parents often arrive at clinic with sleep trackers showing genuinely low sleep efficiency.
• Bedtime anxiety. The child knows that bedtime is difficult, anticipates it, and arrives at the bedtime routine already braced. The anticipatory anxiety becomes its own barrier.
• School-day knock-on. Under-slept autistic children show up as worse sensory tolerance, more meltdowns, lower social capacity, more difficulty with school transitions.

The Devnani and Hegde 2015 review covers the clinical picture and the differential considerations (sleep apnoea, RLS, gastrointestinal contributors) that need to be on the table for the wider assessment ^[1].

Sensory factors

The sensory profile that is present in the daytime continues into the night. Generic "make the bedroom calm" advice often misses the specific input that is the actual problem. Working through the sensory specifics is one of the highest-yield interventions parents can do at home.

A practical sensory audit:

• Sound. Is there a hum the child notices? Heating, refrigerator, neighbours, traffic? White noise or pink noise often helps; sometimes silence is the answer.
• Light. Streetlights, hallway light through the gap under the door, electronic standby lights. Blackout blinds and a complete dark adjustment often help.
• Touch. Bedding texture, pyjama seams, weight of duvet. Weighted blankets have some evidence in autistic children and many families find them useful; check the weight is appropriate for the child's weight.
• Temperature. Many autistic children prefer cooler bedrooms; some prefer warmer. The point is to match the specific child.
• Smell. Some children are bothered by laundry detergents, room scents, food smells lingering in the house. Worth checking.

The Cuomo 2017 meta-synthesis of sleep interventions for autistic children documented that sensory-environmental modification is consistently the most effective non-pharmacological intervention ^[2].

Routine and predictability

The same routine, in the same order, at the same approximate time, every night. The predictability is doing the work; departures from the routine often cost more than they look like they should.

A few practical points:

• The wind-down period needs to be longer than for typical-development children. 60 to 90 minutes is a reasonable target, depending on the child.
• Visual schedules help many autistic children. A simple picture or written sequence of the bedtime steps gives the child the predictability they need to settle.
• Transitions matter. The shift from active play to bath to story is often where things fall apart. Building in micro-transitions (a five-minute warning, a song that signals the next step) is often more useful than expecting the child to switch states immediately. See our pieces on autism sensory accommodations at home and autism meltdowns vs tantrums for the wider sensory and behavioural framework.
• Weekends and holidays. The same routine is more important for autistic children than for typical-development children; the disruption of late weekend bedtimes often costs the whole following week.

Melatonin in autistic children

Melatonin for sleep difficulty in autistic children is one of the few areas where the UK has a specifically licensed product. Slenyto (paediatric prolonged-release melatonin) is licensed in the UK for the treatment of insomnia in children and adolescents aged 2 to 18 with autism spectrum disorder or Smith-Magenis syndrome, where sleep hygiene measures have been insufficient ^{[6, 7]}. The licensing is unusual; most melatonin use elsewhere in the UK is off-label.

Practical points:

• Slenyto is prescription-only. It is not available over the counter in the UK, unlike in the US where melatonin is sold as a supplement. UK parents who have read US parenting content sometimes arrive at the GP expecting to buy melatonin in a pharmacy; the position is different here.
• Standard practice is to try sleep hygiene first. NICE guidance and the licensing both expect this. The prescribing clinician will usually want to know what has been tried.
• The evidence base is reasonable. Maras and colleagues' 2018 trial of paediatric prolonged-release melatonin in autistic children with insomnia showed sustained benefit on sleep onset and total sleep time over 24 months, with a reasonable safety profile ^[5].
• It is not a substitute for the environmental work. Melatonin alongside good sensory and routine work tends to do well; melatonin without the environmental work tends to plateau quickly.
• Other forms of melatonin (immediate-release, liquid formulations, off-label prescribing in non-autistic children) are also used in some clinical contexts. The decision is the prescriber's.

The conversation about Slenyto starts with your GP or paediatrician. Where standard hygiene measures have been genuinely tried for several weeks and the picture has not shifted, it is a reasonable next step to discuss. See our melatonin in children: what the UK evidence and licensing says piece for the wider detail.

When SleepFX or specialist help fits

For families where the standard parent-led work has not produced enough change, NeuroFX's sister product SleepFX is a structured paediatric sleep programme designed specifically for neurodivergent children. It draws on the kind of evidence-based behavioural and environmental work that the Cuomo and Bruni reviews document, structured into a programme parents can work through with clinical support.

For complex sleep pictures, paediatric sleep medicine clinics in NHS regional centres handle conditions like sleep apnoea (significantly over-represented in autistic children), parasomnias, and severe circadian rhythm disorders. GP referral is the usual route.

When to seek further assessment

Specific reasons to ask the GP or paediatrician for sleep medicine referral:

• Loud snoring with pauses in breathing (sleep apnoea)
• Severe restlessness in bed, possibly with limb movements (restless legs / PLMD)
• Very late natural sleep onset (after midnight despite trying earlier; delayed sleep phase)
• Significant daytime sleepiness inconsistent with night-time hours
• Severe parasomnias (night terrors, sleepwalking, REM behaviour disorder)
• Sleep difficulty that is significantly affecting school attendance or family function

What this means in practice

• 50 to 80 percent of autistic children have clinically significant sleep difficulty; the mechanisms (melatonin, sensory, routine, cognitive carry-over) are well-described.
• Sensory-environmental modification is consistently the most effective non-pharmacological intervention (Cuomo 2017).
• The bedtime routine needs to be predictable, in the same order at the same time; the wind-down needs to be longer than for typical-development children.
• Slenyto is the UK-licensed paediatric melatonin for autism; prescription-only, used where hygiene measures have been insufficient. The Maras 2018 long-term trial supports its use.
• For complex pictures, paediatric sleep medicine clinics handle sleep apnoea, parasomnias and severe circadian disorders. NeuroFX's SleepFX is the right structured-support route for the in-between cases.

When to speak to a professional

Speak to your GP or paediatrician if the standard environmental and routine work has been genuinely tried for several weeks and the picture has not shifted, particularly if your child shows daytime sleepiness, severe bedtime distress, or signs of a specific sleep disorder (snoring with pauses, restless legs, very late onset, parasomnias). NeuroFX offers child autism assessment where the diagnostic picture is not yet clear; SleepFX offers structured sleep-programme support for neurodivergent children.

Sources

1. Devnani PA, Hegde AU. Autism and sleep disorders. Journal of Pediatric Neurosciences. 2015;10(4):304-307.
2. Cuomo BM, Vaz S, Lee EAL, Thompson C, Rogerson JM, Falkmer T. Effectiveness of sleep-based interventions for children with autism spectrum disorder: a meta-synthesis. Pharmacotherapy. 2017;37(5):555-578.
3. McLay LK, France K. Empirical research evaluating non-traditional approaches to managing sleep problems in children with autism. Developmental Neurorehabilitation. 2016;19(2):123-134.
4. Bruni O, Angriman M, Calisti F, et al. Practitioner review: treatment of chronic insomnia in children and adolescents with neurodevelopmental disabilities. Journal of Child Psychology and Psychiatry. 2018;59(5):489-508.
5. Maras A, Schroder CM, Malow BA, et al. Long-term efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. Journal of Child and Adolescent Psychopharmacology. 2018;28(10):699-710.
6. NICE. Slenyto (prolonged-release melatonin) for treating insomnia in children with autism spectrum disorder. https://www.nice.org.uk/
7. British National Formulary for Children (BNFc). https://bnfc.nice.org.uk/
8. National Autistic Society. Sleep and autism (children). https://www.autism.org.uk/